About
Small Molecules, Diagnostics
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
118
By Phase
PHASE1/PHASE2: 2PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT05585658Lead Sponsor
A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002
PHASE1/PHASE2Completed
42 participants
Started: Oct 16, 2021 · Completed: Dec 16, 2021
NCT03886662Lead Sponsor
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
PHASE1/PHASE2Recruiting
47 participants
Started: Apr 30, 2019 · Completed: Jul 31, 2021
NCT01837667Lead Sponsor
Phase I Study of LB-100 With Docetaxel in Solid Tumors
PHASE1Completed
29 participants
Started: Feb 28, 2013 · Completed: Sep 30, 2016
Locations (1)
Headquarters
Pasadena, CA, United States
Map
Loading map...